Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway

Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. Currently, no drug is able to cure breast cancer–associated bone metastasis. In this study, we focused on statins that are known to inhibit cholesterol p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:FASEB J
Päätekijät: Wang, Luqi, Wang, Yue, Chen, Andy, Teli, Meghana, Kondo, Rika, Jalali, Aydin, Fan, Yao, Liu, Shengzhi, Zhao, Xinyu, Siegel, Amanda, Minami, Kazumasa, Agarwal, Mangilal, Li, Bai-Yan, Yokota, Hiroki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Federation of American Societies for Experimental Biology 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894072/
https://ncbi.nlm.nih.gov/pubmed/31585508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201901388R
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia